Sanofi (Finland)

Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study

H Yki-Järvinen, Mirja Tiikkainen, Markku Vähätalo et al. · Diabetologia · 2006 · 435 citations · Full text

Metabolic Syndrome, Diabetes Management, Insulin Glargine +10

Initiate Insulin by Aggressive Titration and Education (INITIATE)

Hannele Yki‐Järvinen, Leena Juurinen, Michael Alvarsson et al. · Diabetes Care · 2007 · 137 citations · Full text

Long-Term Weight Maintenance after a 17-Week Weight Loss Intervention with or without a One-Year Maintenance Program: A Randomized Controlled Trial

Tuula Pekkarinen, Jarmo Kaukua, Pertti Mustajoki · Journal of Obesity · 2015 · 43 citations · Full text

Cost-utility of First-line Disease-modifying Treatments for Relapsing–Remitting Multiple Sclerosis

Erkki Soini, Jaana Joutseno, Marja‐Liisa Sumelahti · Clinical Therapeutics · 2017 · 33 citations · Full text

Cost Effectiveness, Neurology, Clinical Trials +1

Cost-effectiveness of influenza vaccination with a high dose quadrivalent vaccine of the elderly population in Belgium, Finland, and Portugal

Fabián P. Alvarez, Pierre Chevalier, Matthias Borms et al. · Journal of Medical Economics · 2023 · 23 citations · Full text